GLP-1: A Major Advance in Diabetes Management
GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial development in how we treat diabetes mellitus . These injectable therapies help mimicking the body’s inherent GLP-1 process, which supports glucose regulation and lowers glucagon secretion . Beyond glucose man